Immunotherapy represents a promising frontier in the fight against breast cancer. By harnessing the body's immune system to recognize and destroy cancer cells, this approach has shown significant efficacy in certain types of breast cancer, especially those that are triple-negative or have high levels of PD-L1 expression. Ongoing research and clinical trials continue to explore its potential, making immunotherapy a hopeful prospect for many patients.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.